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“Evaluation of Knowledge Regarding Diagnostic Strategies for Genetic Diseases in
Select Residents”
Publication No. ____
Samantha J. Penney, B.A.
Supervisory Professor: Sarah J. Noblin, M.S. C.G.C.
Genetics education for physicians has been a popular publication topic in the
United States and in Europe for over 20 years. Decreasing numbers of medical
genetics professionals and an increasing volume of genetic information has created a
dire need for increased genetics training in medical school and in clinical practice. This
study aimed to assess how well pediatrics-focused primary care physicians apply their
general genetics knowledge to clinical genetic testing using scenario-based questions.
We chose to specifically focus on knowledge of the diagnostic applicability of
Chromosomal Microarray (CMA) technology in pediatrics because of its recent
recommendation by the International Standard Cytogenomic Array (ISCA) Consortium
as a first-tier genetic test for individuals with developmental disabilities and/or
congenital anomalies. Proficiency in ordering baseline genetic testing was evaluated for
eighty-one respondents from four pediatrics-focused residencies (categorical
pediatrics, pediatric neurology, internal medicine/pediatrics, and family practice) at two
large residency programs in Houston, Texas. Similar to other studies, we found an
overall deficit of genetic testing knowledge, especially among family practice residents.
Interestingly, residents who elected to complete a genetics rotation in medical school
scored significantly better than expected, as well as better than residents who did not
elect to complete a genetics rotation. We suspect that the insufficient knowledge
among physicians regarding a baseline genetics work-up is leading to redundant (i.e.
concurrent karyotype and CMA) and incorrect (i.e. ordering CMA to detect
achondroplasia) genetic testing and is contributing to rising health care costs in the
United States. Our results provide specific teaching points upon which medical schools
can focus education about clinical genetic testing and suggest that increased
collaboration between primary care physicians and genetics professionals could benefit
patient health care overall.
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Background

The field of genetics is rapidly expanding, resulting in an increasing number of
genetic tests available for clinical application. It has been predicted that primary care
providers will feel an increased demand to provide information on these newly available
genetic tests and their results [1,2,3,4]. Once born, a child first comes into contact with
the health care system through his/her primary care provider (PCP). It is known that 35% of all children are born with a birth defect [5] and sometimes these birth defects can
indicate an underlying genetic condition which should be diagnosed quickly and
accurately. A child’s pediatrician should refer them to a genetics specialist if a genetic
etiology is suspected. Once a patient arrives in a pediatric genetics clinic, an accurate
diagnosis is the desired end-point so that families will have correct information about
the prognosis, potential treatments and recurrence risk.
We have seen, through our experiences at Children’s Memorial Hermann
Hospital and Lyndon B. Johnson General Hospital, both in Houston, Texas, that
children and adolescents are commonly referred to our genetics clinic upon suspicion
of genetic disorders such as Neurofibromatosis type I and Marfan syndrome. However,
many of these children have had no work up at all prior to their referral. Patients are
also referred with a confirmed diagnosis of Down syndrome, for example, only to find
out that they were diagnosed using CMA, when a karyotype is still the ‘gold standard’
for diagnosis [6].
We propose that diagnosis using non-ideal methods is in part due to a lack of
adequate training in genetics in medical schools and pediatrics-based residency
programs. There have been several studies performed in the United States, as well as
in Europe and Canada, looking at physicians’ knowledge of genetics (i.e. inheritance
patterns of genetic condition, knowledge about screening for genetic conditions)
[7,8,9,10,11,12]. These studies have consistently shown a deficit in knowledge. Many
of these studies have focused on cancer genetics knowledge, with few studies focusing
on primary care physicians’ (PCP) knowledge of which genetic tests are most
appropriate in a clinical pediatrics setting.
1

Thus, in the current study, we aimed to assess how knowledgeable pediatricsfocused residents are about clinical testing, including chromosomal microarray (CMA),
in order to highlight specific areas for which current medical school and residency
program curricula can be improved. Such improvements will enable physicians to
become more comfortable ordering first-tier genetic testing, expedite time to diagnosis
and decrease the unnecessary spending of health care dollars by patients and
insurance companies.
Since the Human Genome Project’s contribution to the knowledge of genetic
causes of human diseases, genetics has become a more frequent topic of discussion in
mainstream medicine [2]. In less than 10 years since the completion of the project,
whole exome sequencing has become clinically available [13]. Now, the thousands of
genes in the human genome can be analyzed, often at a lower cost than individual
gene analysis. In addition, the rise in popularity of direct-to-consumer (DTC) genetic
testing in 2007 [14] has enabled patients to receive personalized genetic testing results
without first consulting with their doctor, leaving PCPs and other medical professionals
to retroactively interpret the results. Two studies performed in the United States found
that 15-19% of PCPs have had at least one patient come to an appointment with
questions about personal genomic testing results, that were ordered directly from a
DTC company [15,16]. Additionally, the majority of patients who have had DTC testing
expect that their doctors will be conversant enough in genetics to be able to explain
and interpret the results of that testing [17].
Insufficient Genetics Workforce
Typically, genetic testing, like whole exome sequencing and chromosomal
microarray analysis, is ordered by medical geneticists; however the current workforce
of genetics professionals is not able to meet demand. The Royal College of Physicians
estimated that for every 250,000 people, one full-time geneticist is required [18]. From
this report, it has been extrapolated that the United States requires 1,232 full time
clinical geneticists for adequate population coverage [19]. According to the American
Board of Medical Genetics (ABMG), there are currently a sufficient number of clinical
2

geneticists to support our population; however the number of clinical geneticists
receiving board certification per year has decreased over the last 30 years [20].
Additionally, according to the ABMG 2003 survey of certified geneticists, the majority of
clinical geneticists in the United States and in Canada report their practices as nearly
full or full, with a little over half being able to accept a new patient within three weeks
[21,22]. When stratified by subgroup, half of pediatric geneticists have new patient wait
times of up to 3 months and only 5% of pediatric geneticists can see a new patient
within one week [23]. Furthermore, 60% of the geneticists surveyed by ABMG feel that
the demand for geneticists exceeds the supply. As a follow up to ABMG’s 2003 study of
the genetics workforce, Cooksey et al., showed that 41% of patients seen by pediatric
geneticists require more than one visit to complete a diagnostic evaluation [23]. In
order to make the best use of the limited resource of a clinical genetics visit, PCPs
could consider ordering first-tier testing so that the results will be available when the
patient visits a genetics clinic for the first time.
Genetic Testing
A genetics work-up often includes evaluation of a patient for specific clinical
features (e.g. a heart defect or abnormal skin pigmentation) as well as molecular
genetic testing. For the purposes of this study, ‘first-tier’ or baseline testing for clinicallydiagnosable genetic conditions aims to rule in or rule out pathognomonic or diagnostic
criteria (i.e. Lisch nodules in a patient with suspected Neurofibromatosis type I).
Baseline molecular testing includes methodologies such as single gene analysis,
karyotype, and Chromosomal Microarray (CMA). Baseline molecular testing also
includes methodologies outlined by consensus recommendations. For example, The
American College of Medical Genetics (ACMG) currently recommends a 23-mutation
panel for use in general population screening for cystic fibrosis [24]. Additionally, the
American College of Obstetrics and Gynecology (ACOG) issued a consensus
statement in 2011 stating that complete sequencing of the entire CFTR gene that is
known to cause cystic fibrosis is never appropriate for carrier screening due to the risk
of receiving difficult-to-interpret results [25]. Similar statements exist for several of the
conditions, such as Fragile X and phenylketonuria, that were chosen as the focus of the
current study [26,27].
3

Specific attention should be paid to the ACMG’s recently published guidelines
for use of array-based technology [28] as well as the International Standard
Cytogenomic Array (ISCA) Consortium’s recommendation of array-CGH (chromosomal
microarray, CMA) as a first-tier clinical diagnostic test for persons with unexplained
developmental disability, autism spectrum disorders, or multiple congenital anomalies
[29]. When CMAs were first ordered for the evaluation of microdeletions and
microduplications in a patient, a standard karyotype was often concurrently ordered.
Today, it is recognized that with the exception of CMA’s inability to detect balanced
translocations, karyotypes are redundant testing when ordered alongside a CMA. On
the other hand, CMAs do not detect point mutations or trinucleotide repeat mutations
responsible for the majority of genetic disorders like achondroplasia and Fragile X,
respectively. Our experience has been that many health care providers are still
ordering a CMA and karyotype together, or are ordering a CMA for single gene
disorders, like achondroplasia, that it cannot detect. For this reason, we chose to
emphasize CMAs in our study.
Primary Care Providers as Gatekeepers
Primary care providers have first contact with undiagnosed patients and are
responsible for continuing to care for patients once they receive a diagnosis. Thus, it
has been proposed that PCPs act as gatekeepers to specialists such as medical
geneticists [30,31]. Without supplanting the role of genetics professionals, it is crucial to
educate PCPs about baseline genetic testing that can be completed prior to a genetics
consultation if they are to take on a more active gatekeeper role. Many children are
referred to our genetics service with little to no previous work up, meaning they must be
seen multiple times before a diagnosis is achieved. This increases the overall cost to
families.
Health Care Costs
The case scenarios in our study ask residents to choose the next most
appropriate first-tier genetic test/clinical action in conjunction with a referral to a
genetics specialist. There are several genetic testing methodologies that can give a
4

correct diagnosis; however, it would be prudent for physicians to know the
methodologies that give the maximum information in the most straight-forward manner
for medical management, recurrence risk, and for cost savings purposes.
Many genetic diagnoses can be established by both direct and indirect methods.
Obviously, the most direct method early in an individual’s evaluation will lead to a
reduction in health care costs. In 2009, health care spending in the United States was
the highest of all industrialized countries, totaling $2.5 trillion dollars or 17.6% of the
nation’s Gross Domestic Product (GDP) [32]. Certainly this cost is driven up by
duplicate and redundant genetic testing. A case example that we focused on with the
current study is the diagnosis of Down syndrome. Students learn through
undergraduate genetics courses and/or in medical school that Down syndrome is
caused by extra material from chromosome 21. Ninety-five percent of cases of Down
syndrome are caused by the sporadic occurrence of an extra chromosome 21 and 34% of cases are caused by a translocation involving an extra chromosome 21.
Additionally, 1-2% of cases are due to mosaicism [33]. Each genetic cause of Down
syndrome has a different recurrence risk [34]. The ‘gold-standard’ for diagnosis of any
aneuploidy, including Down syndrome, is through standard karyotype, enabling
differentiation between a free trisomy, a translocation, and mosaicism [6]. There are
other genetic testing methodologies, such as fluorescence in-situ hybridization (FISH)
or CMA that can be used to make the suspected diagnosis because both confirm the
presence of extra material from chromosome 21. However, neither FISH nor a CMA
can determine whether the extra chromosome 21 material is from a free trisomy or a
translocation [35]. While medical management can be carried out based on FISH or
CMA results, the American Academy of Pediatrics recommends that a positive FISH
result be confirmed with a karyotype [33].
In summary, there are many methods to determine a diagnosis of Down
syndrome, but a karyotype is recommended because it gives the most complete
information necessary for accurate characterization of recurrence risk. We specifically
included this scenario in our study in order to investigate whether residents are
mistakenly ordering incorrect or redundant testing for Down syndrome. There are
5

several other situations for which redundant testing is frequently ordered so the
discussion of Down syndrome can be extrapolated to those as well.
Medical School and Resident Education
To combat increasing health care spending on genetic testing, PCPs must
receive more education about genetic testing in medical school and in residency.
Several taskforce and work group investigations [4,36,37] have explored the idea that
medical schools and residency programs are not preparing PCPs to provide genetic
services and information to their patients. While there are numerous articles touting the
lack of and need for genetics education in medical schools and residency programs in
the U.S. [38], there are recognized obstacles to integrating genetics into medical school
and residency program curricula. These obstacles include: a crowded curriculum, lack
of knowledgeable faculty, a disconnect between basic sciences and clinical
experiences during training, failure to integrate genetics across the curriculum,
inadequate representation of genetics on certifying exams, and lack of management
and referral guidelines in genetics [39].
The Accreditation Council for Graduate Medical Education (ACGME) is
responsible for releasing guidelines by which medical residencies must structure their
residency programs. According to ACGME guidelines[40], pediatric residents must
complete seven months of subspecialty training and have the option to rotate through
genetics among other choices. Thus, at the residency level, genetics is not a required
rotation in pediatrics. Additionally, according to ACGME guidelines, genetics is an
optional area of study in pediatric neurology and is not mentioned in the guidelines for
family practice or pediatric internal medicine residencies [41,42,43]. Without proper
training, pediatric-focused PCPs will not be familiar with the appropriate use of basic
clinical genetic testing such as karyotypes, FISH, microarray and other molecular
testing to evaluate pediatric genetic syndromes.
In order to prepare graduating medical students for applying genetics
information to their patients’ conditions, medical schools should focus on teaching the
clinical application of genetics in addition to basic genetics information including
6

inheritance patterns. The University of Texas Medical School at Houston (UT) does
require their students to take genetics in medical school, although the course is not a
semester-long course like many others. Furthermore, genetics is a required two-week
rotation in the pediatrics residency program at UT [44]. There are other medical
schools, like Baylor College of Medicine, that are beginning to offer special programs or
‘tracks’ to students interested in genetics. These programs are working to incorporate
more genetics into the curriculum for everyone else, too [45,46]. Restructuring medical
school curriculum as these programs have done shows potential to integrate more
training in genetics into medicine.
Originally, research showed that not only did primary care providers have
inadequate genetics education and knowledge, but that they were also reluctant to
remedy this problem [47]. However, more recent studies have found that PCPs
acknowledge a need to increase their genetics knowledge [36,48]. Several strategies to
address these issues have been proposed by PCPs and clinical genetics professionals.
These include Continuing Medical Education (CME) courses, lectures, case-based
educational material that can be integrated into residency training programs and short
internships with genetics professionals. Each solution has advantages and
disadvantages that should be explored in order to best suit the needs of PCPs at all
levels of training.
Many diseases have a genetic component; as such, it is important for most
medical specialties to have some working knowledge of how disease is influenced by
genetics. While most children enter a genetics clinic through a referral from their PCP,
there must be a balance between under and overeducating these generalists about
genetics. Since PCPs do not seem to be adequately educated in the clinical application
of genetic testing, how should they proceed when caring for their patients with a
suspected genetic disease? Essentially, there are two choices: one, PCPs could order
no genetic testing and refer all patients with suspected genetic conditions to medical
geneticists. Alternatively, PCPs could continue as they have been, ordering genetic
tests in conjunction with a referral to a medical geneticist. There are advantages and
disadvantages to both approaches that can be considered separately.
7

Even in the first scenario where PCPs order no genetic testing but refer instead
to a medical geneticist, there is a certain level of basic genetics knowledge needed for
PCPs to identify patients who might benefit from such a consult. In this case, a PCP
would need to recognize facial and/or body features that might characterize a genetic
syndrome. The strategy of referring patients for a genetics consultation will ensure that
genetic testing is only ordered by the ‘experts’, an ideal solution if one only cares to
decrease wasteful healthcare spending. However, this strategy will likely necessitate
more visits with the genetics team before a diagnosis is reached, placing extra strain on
genetics clinics that currently have new-appointment wait times of 3 months or longer
[23]. The first visit for these patients will entail an evaluation with ordering of preliminary
tests and subsequent visits will be needed for interpretation of the first round of genetic
testing and the addition of second-tier testing, when necessary. A problem with the
approach outlined above is aforementioned insufficiency of the genetics workforce,
such that we will be unable to meet future demands of the population. Furthermore,
Huang et al., (2002) found that for children with Williams syndrome, an earlier
diagnosis reduced the number of tests necessary for the child’s medical care. This
decrease in cost is likely due in part to the specific health care guidelines that exist for
children with Williams syndrome that allow their medical care to be extremely focused
[49]. Reaching a diagnosis in the fewest visits possible is likely to reduce financial
burdens on families with children who have genetic conditions.
Alternatively, PCPs could continue ordering genetic testing to the best of their
abilities in conjunction with a referral to a genetics specialist. There is evidence,
however, that this approach is resulting in increased health care-related costs. ARUP
laboratories found that over an eleven-month period in 2010, genetic counselors
employed by their laboratory identified and cancelled or changed inappropriately
ordered genetic tests, totaling an average of $36,500 per month [50]. Certainly, some
of this ordering error could be due to unfamiliarity with test requisition forms, which
often vary between laboratories. Additionally, it is not possible to tell if the doctor filled
out the requisition form or if it was filled out by a nurse or other employee. Thus, it is
conceivable that the correct test was requested by the doctor, but marked incorrectly
8

on the requisition form by another individual. ARUP also found that 17% of misordered
tests were for a cystic fibrosis panel with reflex to full sequencing of the cystic fibrosis
gene, CFTR. While rare in comparison to many indications for which a child might see
a PCP, cystic fibrosis is a common genetic condition among individuals of Caucasian
descent, with an incidence of 1 in 2,500. Cystic fibrosis is caused by homozygous
mutations in the cystic fibrosis transmembrane conductance regulator protein (Cftr)
encoded by the CFTR gene. One mutation is inherited from each parent that prevents
the Cftr protein from working correctly leading to a buildup of mucus in the lungs,
gastrointestinal, and pancreas of affected patients [51]. Among non-Hispanic
Caucasians, 88% of mutations responsible for cystic fibrosis are detected by the 25common mutation panel recommended by The American College of Medical Genetics
(ACMG) [51]. The detection rate is higher among Ashkenazi Jews and lower among
individuals of African American or Hispanic American descent. Thus, for most
individuals of Ashkenazi Jewish or non-Hispanic Caucasian descent, the common
mutation panel, that costs $210 [52], is appropriate and adequately detects most
common mutations responsible for cystic fibrosis. In an individual of Hispanic American
descent, a healthcare provider might consider ordering full sequencing of the CFTR
gene to bring the detection rate for mutations up from 57% to 98.7%. The cost of full
sequencing however is $1,870. The difference between a common mutation panel and
full sequencing might be difficult to appreciate without sufficient background knowledge
of genetic testing methodologies and differences in carrier frequencies among various
ethnic groups. If PCPs continue to order genetic testing for cystic fibrosis, they must be
educated on the suitability of different testing methodologies for different ethnic groups
to ensure that ordering of wasteful genetic testing is decreased.
Because it has been suggested by focus groups that case-based genetics
education might be a helpful tool to increase knowledge of genetics and genetic testing
in primary care [48], the current study aimed to evaluate current knowledge in a subset
of pediatric-focused medical residents when given hypothetical clinical scenarios.
These scenarios were designed to be representative of common clinical situations that
might be encountered by a generalist working with children. We aimed to identify
weaknesses, if present, in the current state of clinical genetics testing knowledge as
9

part of an overall movement to increase the quality of medical services available to the
pediatric population.
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Materials and Methods

Study Design
The survey-based study was designed to assess the knowledge of first-tier
genetic testing among pediatric-focused residents since these are the specialties most
likely to encounter a child with an undiagnosed genetic condition. A survey of casebased scenarios was used to assess the current working knowledge of medical
residents at The University of Texas Medical School at Houston (UT) and Baylor
College of Medicine in four different pediatric-focused residencies. Demographic
information was also obtained on the responders. Comparisons were made between
residency programs, residency specialties, year of residency, and prior experience and
education. We hypothesized that all residents would have a deficit of knowledge with
regard to ordering genetic testing as part of a baseline genetics work-up.
Study Population
Residents were recruited for this study from the following pediatric-focused
specialties: Categorical Pediatrics, Medicine/Pediatrics (Med/Peds), Pediatric
Neurology (Pedi Neuro), and Family Practice. Residents were recruited from all years
of residency. Participating institutions were The University of Texas Medical School at
Houston (UT) and Baylor College of Medicine (BCM), both in Houston, Texas.
Residents were invited to participate in the study by a series of emails sent over
a 4-month period. Data collection was initiated on November 21, 2011, and completed
on March 23, 2012. The emails were sent to the residents by their program directors
and no identifying information was made available to the primary investigator and
committee. The emails included a link to the survey in SurveyMonkey® (Appendix A).
The study was educational in nature, thus it was considered exempt by the
Institutional Review Boards (IRBs) at UT (HSC-MS-11-0574) and BCM (H29897). As
required by the IRB process, the email sent to the residents included the purpose of the
study along with information on the voluntary and anonymous nature of their
participation in the study. This information was repeated on the first page of the survey
11

and participants were asked to consent by clicking that they understood (Appendix B).
There was no financial incentive offered for completion of the survey.
The questionnaire included 33 items assessing general demographic
information, previous experience with genetics, and prior education, as well as 15
scenario-based questions to assess genetic testing knowledge. Most of the
demographic information was collected using multiple choice questions; however,
some questions provided areas for free response. Additionally, respondents were given
the opportunity to enter comments about the survey upon completion. Each scenariobased question focused on one genetic condition. The genetic conditions were chosen
based on those that are commonly seen in genetics clinic as well as on genetic
conditions that residents must be familiar with in order to pass their board examinations
[53]. The questions were written by the primary investigator and reviewed by the
committee. An answer was deemed correct by the investigating committee based on
their experience and recommendations from various professional organizations and
websites (e.g. ACMG and GeneTests.org). The study did not aim to assess residents’
ability to recall a genetic condition based on clinical features. Thus, for some scenarios,
the question provided the residents with the suspected diagnosis, enabling them to
focus on choosing only the genetic testing needed to confirm the particular diagnosis,
as opposed to unnecessarily ordering a full work-up.
For all genetic tests in the survey, prices charged to insurance companies were
obtained from the clinical laboratories, hospital, or clinic that offers the tests (Appendix
C). When insurance pricing was not available, institutional prices were used. Price
information was obtained from the following laboratories, hospitals, and/or clinics:
Baylor College of Medicine Medical Genetics Laboratories in Houston, TX; Children’s
Memorial Hermann Hospital in Houston, TX; City of Hope Molecular Diagnostic
Laboratory in Duarte, CA; Esoterix, Inc. in Austin, TX; Fisher Scientific
(http://www.fishersci.com); Greenwood Genetic Center in Greenwood, SC; Robert
Cizik Eye Clinic in Houston, TX; The Ohio State University Medical Center in
Columbus, OH; and the University of Oklahoma Health Sciences Center Genetics
Laboratory in Oklahoma City, OK. It was assumed that for each hypothetical patient
12

scenario, correct genetic testing would have eventually been ordered, even if not a by
the primary care provider. Thus, in order to assess the total cost of diagnosis for the
hypothetical patient, the price of the correct genetic test was added to all incorrect
answer options that did not already include the correct test. Cost analysis was
performed for select questions comparing residents who responded correctly to those
who responded incorrectly.

Statistical Analysis
Data collected from SurveyMonkey® was exported to Microsoft® Excel and then
into STATA®10 (STATA Corporation, College Station, TX) for analysis. All data was
analyzed using p values that were significant if < 0.05. Percent score was calculated as
the number of questions each respondent got correct out of the total number they
answered, regardless of whether they answered all questions. For variables comprised
of two groups, t-tests were run to test for significance of effect on overall percent score
(H0 = mean percent score is the same for both groups). For variables comprised of
more than two groups, classical one-way ANOVA was run to test for significance of
effect on overall percent score (H0= mean percent score is the same for all groups) with
posthoc Tukey tests to identify which group was different, if any. Additionally, percent
score was compared between those residents who answered only the first five
questions and those residents who answered more than five questions, between
residency programs, and between residency specialties. Variables found to be
significant by univariate analysis were analyzed using linear regression when
appropriate, then examined with multivariate analysis.
Three members of the committee and one outside genetics professional
assigned each scenario-based question a value for the expected percentage of
residents that should correctly answer the question (expected correct rate). The values
were assigned between 0% and 100% in 25% increments. To prevent bias, expected
correct rates were determined before these individuals had seen the results of the
study. Subsequent analysis of expected correct rates showed raters to be in ‘fair’
agreement based on Interpretation of Kappa adapted by Viera and Garrett (2005) [54]
13

(kappa statistic = 0.35). An average of these values (average expected correct rate)
was used to run a binomial probability test to determine whether the observed correct
rate differed significantly from the expected correct rate.
For each scenario-based question, several variables were tested with chi2 for
association with percent score overall and with correct answer rates per individual
question. These variables included general demographics, information about current
residency program, educational history, and about residents’ families such as the
number of children they have and whether anyone in their family had ever been
diagnosed with a genetic condition. See Appendix D for a complete listing of variables.
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Results

General Demographics and Response Rates
Table 1 summarizes the study population stratified by residency program,
residency year, and specialty. At UT, the majority of eligible participants were residents
in categorical pediatrics (48.9%, 68 of 139), followed by family practice (25.9%, 36 of
139), medicine/pediatrics (16.5%, 23 of 139), and pediatric neurology (8.6%, 12 of
139). At BCM, the majority of eligible participants were also residents in categorical
pediatrics (75.0%, 111 of 148), followed by medicine/pediatrics (20.9%, 31 of 148),
then pediatric neurology (4.1%, 6 of 148). Residents from the BCM family practice
program never received the invitation to participate in the study. Overall, the majority of
eligible participants were residents in categorical pediatrics (62.4%, 179 of 287),
followed by medicine/pediatrics (18.8% 54 of 287), then family practice (12.5%, 36 of
287), and finally pediatric neurology (6.3%, 18 of 287).
Of the 287 residents that were eligible to participate in the study, we received
responses from 106 individuals giving us a 36.9% percent response rate. Nineteen
respondents were excluded from analysis because they did not answer any scenario
questions, resulting in a total of 87 respondents. Among the 87 respondents, six more
were excluded because they were either not in one of the four residencies examined by
this study, no longer in a residency program, or not affiliated with BCM or UT. The final
number of respondents analyzed was 81 (28.2% response rate).
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Table 1: Study Population Stratified by Residency Program, Residency Year, &
Residency Specialty

Program

UT

BCM

Totals

Year Pediatrics
PGY-1
PGY-2
PGY-3
PGY-4
PGY-5
PGY-1
PGY-2
PGY-3
PGY-4

22
20
26
0
0
68
36
35
40
0
111
179

Medicine/ Pediatric
Family
Pediatrics Neurology Practice
6
2
12
4
3
12
6
3
12
7
3
0
0
1
0
23
12
36
8
5
n/a
8
3
n/a
8
0
n/a
7
0
n/a
31
8
n/a
54
20
36

139

150
289

Table 2 summarizes general demographic information of respondents. The
majority (72.8%, n=59) were female, in residency at UT (63.0%, n=51), and had
attended medical school in the United States (82.7%, n=67). In addition, the majority of
respondents (60.5%, n=49) were younger than 30 years of age. For demographic
information collected by free response, investigators analyzed data in groups created
after the collection of data was complete (i.e. undergraduate majors were grouped into
‘Biology/Health, Other Science, and Liberal Arts categories). When more than one
major or minor was listed, respondents were grouped using whichever major or minor
theoretically would have given them more instruction in genetics. Most respondents
(55.6%, n = 45) majored in a Biology/Health field at their undergraduate institution (e.g.
biology, biomedical science, biology and molecular genetics). Most respondents
(65.0%, n=53) did not complete a genetics rotation in medical school, although eight
respondents (10.0%) elected to complete a genetics rotation in medical school even
though it was not required.
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Table 2: General Demographic Information of Respondents
Sex
Male
Female
No response
Age

Number
21
59
1

%
25.9
72.8
1.2

Younger than 30 years

49

60.5

30-34 years

19

23.5

Older than 34 years

13

16.1

51
30

63.0
37.0

67
14

82.7
17.3

11
70

13.6
86.4

45
12
18
6

55.6
14.8
22.3
7.4

6
12
14
49

7.4
14.8
17.3
60.5

8
53
12
81

10
65.0
25.0

Residency Program
UT
BCM
Attended Medical School in the US
Yes
No
Post-call on day of survey
Yes
No
Undergraduate Major
Biology/Health
Other Science
Liberal Arts
No response
Undergraduate Minor
Biology/Health
Other Science
Liberal Arts
No response/No minor
Nature of Genetics Rotation in Medical School
Elective
No Rotation
No Response
Total

Table 3 summarizes residency information for the 81 respondents analyzed in
this study. Most responders were categorical pediatrics residents (63.0%, n=51),
followed by family practice (18.5%, n=15), medicine/pediatrics (12.3%, n=10), and
finally pediatric neurology (6.17%, n=5). Except for family practice, roughly equal
numbers of responses were received from UT and BCM in each specialty. For UT and
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BCM, most residents were from categorical pediatrics (n=28 and n=23, respectively).
The fewest responders were from pediatric neurology (n=3 and n=2, respectively).
Table 3: Summary of Number of Respondents by Residency Specialty, Year, and
Medical School Affiliation
Program

UT

BCM

Year

Pediatrics

Medicine/
Pediatrics

Family
Practice

Pediatric
Neurology

PGY-1
PGY-2
PGY-3
PGY-4
PGY-5
Total
PGY-1
PGY-2
PGY-3
PGY-4
Total

8
10
10
0
0
28
10
4
8
1
23
51

2
1
2
0
n/a
5
2
2
1
0
5
10

8
4
3
n/a
n/a
15
n/a
n/a
n/a
n/a
n/a
15

1
1
0
0
1
3
1
1
0
0
2
5

Totals

51

30
81

Table 4 shows response rate by residency year stratified by residency program.
The overall response rate for the study was 28% (81/287). The response rate was
higher for UT than for BCM (35% vs. 20%) and the response rate was highest among
residents in the UT family practice and categorical pediatrics residency programs (42%
and 41%, respectively).
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Table 4: Response Rates by Residency Year Stratified by Residency Program

Program

UT

BCM

Totals

Medicine/

Family

Pediatric

Pediatrics

Practice

Neurology

36%

33%

67%

50%

PGY-2

50%

25%

33%

33%

PGY-3

38%

33%

25

0%

PGY-4

n/a

0%

n/a

0%

PGY-5

n/a

n/a

n/a

100%

Total

41%

22%

42%

37%

PGY-1

27%

25%

n/a

25%

PGY-2

12%

25%

n/a

50%

PGY-3

20%

13%

n/a

n/a

PGY-4

n/a

0%

n/a

n/a

Total

20%

21%

n/a

19%

20%

31%

21%

42%

28%

28%

Year

Pediatrics

PGY-1

35%

Case-Based Scenario Questions
Each scenario was given an expected percent correct rate by the investigators.
Because not all respondents completed the entire survey, tables 5, 6, and 7 show
summaries of responses by each page of scenario questions. The tables include
correct answers, expected and observed correct answer rate, and whether the
difference between expected and observed correct answer rate was statistically
significant. The correct answer for each question is italicized.
The observed correct rates were significantly lower than expected for the
scenarios involving Fragile X syndrome, Down syndrome, carrier screening for cystic
fibrosis, Spinal Muscular Atrophy, multiple congenital anomalies, Turner syndrome,
PKU and achondroplasia, (p<0.05). The observed correct rates for the scenarios
diagnosing suspected CF and Marfan syndrome were lower than expected, although
not statistically significant. Interestingly, the observed correct rate was higher than
19

expected for scenarios involving ambiguous genitalia, Prader Willi syndrome, Noonan
syndrome, unspecified hemoglobinopathy, and Neurofibromatosis type I, although
these values were not statistically significant.
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Table 5: Observed and Expected Correct Answer rates for Questions 1-5
Q1: Ambiguous Genitalia

Freq.

%

CMA only
CMA + Karyotype

0
6

0.0%
7.4%

CAH biochemical screen

8

9.9%

CAH biochemical screen + Karyotype

47

58.0%

CAH biochemical screen + Karyotype +
CMA

20

24.7%

Q2: Fragile X
CMA only
CMA + Fragile X testing

5
30

6.2%
37.0%

CMA + Fragile X testing + karyotype

15

18.5%

CMA + karyotype
Fragile X testing only

2
29

2.5%
35.8%

Q3: Down syndrome
CMA only

8

9.9%

FISH for chromosome 21

19

23.5%

Karyotype only

24

29.6%

CMA + FISH for chromosome 21

22

27.2%

CMA + Karyotype

8

9.9%

CFTR deletion testing
CFTR full sequencing
CFTR mutation panel
CMA

9
7
47
4

11.1%
8.6%
58.0%
4.9%

CMA + CFTR mutation panel

14

17.3%

CFTR deletion testing
CFTR sequencing

3
17

3.7%
21.0%

Targeted CFTR for deltaF508

25

30.9%

CFTR mutation panel
CMA
Total (for each question)

33
3
81

40.7%
3.7%

Expected
Correct
Rate

P
value

56.3%

0.666

57.5%

<0.001

62.5%

<0.001

57.5%

0.580

51.3%

0.037

Q4: New baby suspected CF

Q5: CF screening with known
mutation in a partner
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Table 6: Observed and Expected Correct Answer Rates for Questions 6-10
Q6: SMA

Freq.

%

Deletion/Duplication testing SMN1
CMA
Sequencing of SMN1 (all exons)

27
21
13

37.5%
29.2%
18.1%

Sequencing of SMN1 (exons 7 and 8 only)

7

9.7%

Deletion/Duplication SMN1 (exons 7 and
8)

4

5.6%

Q7: Prader Willi syndrome
CMA
FISH for PWS critical region

12
14

16.7%
19.4%

Methylation studies of PWS critical region

24

33.3%

Sequencing of SNRPN
UPD testing for PWS critical region

4
18

5.6%
25.0%

Q8: Multiple congenital anomalies of
unknown etiology
CMA
Karyotype only
Fragile X testing
Metabolic work-up (PAA, UOA, ACP)
Telomere FISH

40
2
6
24
0

55.6%
2.8%
8.3%
33.3%
0.0%

Q9: Turner syndrome
CMA only
Karyotype only
Skeletal survey

14
36
9

19.4%
50.0%
12.5%

Metabolic work-up (PAA, UOA, ACP)

12

16.7%

Telomere FISH

1

1.4%

Q10: PKU
Plasma amino acids + serum PAH

10

13.9%

Immediately refer to metabolic center

5

6.9%

Sequencing of PAH and switch to low Phe
diet

8

11.1%

Repeat NBS and switch to low Phe diet

15

20.8%

Expected
Correct
Rate

P
value

26.3%

<0.001

32.5%

0.614

75.0%

<0.001

73.8%

<0.001

56.3%

<0.001
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Low Phe diet + plasma A.A. + repeat NBS

34

Total (for each question)

72

47.2%

Table 7: Observed and Expected Correct Answer Rates for Questions 11-15
Q11: Noonan syndrome

Freq.

%

CMA only
Karyotype for Noonan syndrome
Karyotype for Turner syndrome
Molecular testing for Noonan syndrome
Molecular testing for Turner syndrome
CMA only
Q12: Marfan syndrome
CMA
Echocardiogram, ophthalmologic exam,
homocystine & methionine panel
Metabolic workup (PAA, UOA, ACP)
Echocardiogram + ophthalmologic exam
RET sequencing responsible for MEN2

12
18
7
31
0
12

17.6%
26.5%
10.3%
45.6%
0.0%
17.6%

3

4.4%

33

48.5%

3
28
1

4.4%
41.2%
1.5%

2

2.9%

4

5.9%

4

5.9%

57

83.8%

1

1.5%

15
1
3
43
6

22.1%
1.5%
4.4%
63.2%
8.8%

40

58.8%

13

19.1%

12

17.6%

3

4.4%

Q13: Unspecified hemoglobinopathy
CMA
Sequencing FVIII and FIX responsible for
hemoglobin A and B
Sequencing of HBB gene responsible for
sickle cell
Hemoglobin electrophoresis, if not already
done
Order sickledex if not already done
Q14: Achondroplasia
CMA
Metabolic work up (PAA, UOA, ACP)
Serum calcium
Skeletal survey
Vitamin D studies
Q15: Neurofibromatosis type I
Diagnose NF1 based on clinical criteria
Diagnose NF1 after molecular testing is
positive
Diagnose NF1 after skin biopsy studies
are positive
CMA

Expected
Correct
Rate

P
value

43.8%

0.667

51.3%

0.371

73.8%

0.983

77.5%

0.005

58.8%

0.551

23

Echocardiogram
Total (for each question)

0
68

0.0%

Figure 1 represents the expected vs. observed score for all 15 case-based
scenario questions. There were eight questions for which residents scored significantly
lower than expected (as indicated with an asterisk).
Figure 1: Expected vs. Observed Score by Scenario

Overall Score
Figure 2 shows the normal distribution of overall score for all respondents (n =
81; p value for skewness = 0.996). The mean overall score was 43.0% (max score =
80%, min score = 0%, SD = 18.9%), which was significantly lower than the expected
mean overall score of 56.9% (p<0.00001). Table 8 shows scores for all respondents
grouped in 20 percent intervals. The majority of respondents received a score of <
60%.
Table 8: Overall Percent Score
Score Groups % (# of respondents)
<20%

6.17 (5)

20-39%

30.86 (25)
24

0

5

Frequency
10

15

20

40-59%
35.8 (29)
60-79
22.22 (18)
=80%
4.94 (4)
Figure 2: Overall Percent Score – All respondents
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There were several variables that significantly affected the observed mean
overall score: number of pages complete, residency specialty, location of medical
school, nature of genetics instruction in medical school, and electing to complete a
genetics rotation in medical school.
Number of Case-Based Scenario Questions Answered
All respondents were grouped according to the number of pages of case-based
scenario questions they answered; either 5 (Page 1 only), 10 (Page 1 and 2 only) or 15
(all three pages). Overall, the percent score was different between these groups
(ANOVA p value=0.0023) (Table 9). Posthoc Tukey test demonstrated a significant
difference in mean score between those who only answered one page and those who
completed all three pages. Additionally, linear regression model demonstrated an
average increase of 11% in percent score for each additional page completed
(p<0.0005). There was a significant difference in overall percent score between those
who completed only the first page and those who completed all three pages (Table 9).
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Table 9: Comparison Overall Score: Number of Pages Completed
# Pages Complete

N

1

9

24.4%

19.4%

2

4

32.5%

17.1%

3

68

46.0%

17.5%

Mean Percent Score Std. Dev. P value*

0.001

*comparing 1 page completed to 3 pages completed
Figure 3 shows percent score for those who only answered the first five
questions (N = 9, p value for skewness = 0.856, mean score = 24.4% (SD = 19.4), min
score = 0%, max score = 60%).

0

1

Frequency
2

3

4

Figure 3: Overall Score: One Page Completed (n=9)

0

20

40
Percent Score

60

80

The nine individuals who answered only the first page and the four individuals
who answered pages 1 and 2 were excluded in Figure 4, which shows the normal
distribution of overall score for those respondents who answered all questions (n = 68;
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p value for skewness = 0.554). The mean score for this group was 46.0% (max score =
80%, min score = 13.3%, SD = 17.5%).

0

5

Frequency

10

15

Figure 4: Overall Score: All Pages Answered (n=68)
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Table 10 shows observed and expected percent correct rate for the first five
scenarios for those individuals who only answered questions 1-5 compared to those
who answered either 10 or 15 questions. Among these questions, only the new baby
with suspected CF question showed a significant difference in correct response rate
between these two groups (22.2% correct versus 60.3% correct, p=0.031). However
collectively, residents who only completed the first five questions had a significantly
lower overall score on those questions than residents who completed all three pages
(24.4% vs. 46.8%, p=0.024).
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Table 10: Comparison of Score, First 5 pages: One page vs. Three pages
complete
Correct Answer Rate
n (%)

P value

All pages
n= 68

First Page
Only n= 9

41 (60.3)

3 (33.3)

0.161

25 (36.8%)

1 (11.1%)

0.130

21 (30.9%)

3 (33.3%)

0.883

41 (60.3%)

2 (22.2%)

0.031

31 (45.6%)

2 (22.2%)

0.188

46.8%

24.4%

0.024

Q1: Ambiguous Genitalia
CAH biochemical screen + Karyotype
Q2: Fragile X
Fragile X testing only
Q3: Down syndrome
Karyotype only
Q4: new baby suspected CF
CFTR mutation panel
Q5: CF screening with known
mutation in a partner
CFTR mutation panel
Mean overall score for first five
question

Residency Specialty
As previously stated, the majority of the respondents (n=51) were categorical
pediatric residents. There were approximately equal numbers of Med/Peds (n=10) and
Family Practice residents (n=15). Pedi Neuro residents accounted for the fewest
number of respondents (n=5). ANOVA comparing mean percent score for these four
groups resulted in a significant difference in means (p<0.00001). Post-hoc tests
showed that family practice residents had significantly lower mean scores than all other
groups and that the other three groups did not differ significantly from each other. While
all groups scored lower than expected (56.9%), overall percent score was only
significantly lower than expected for Pediatrics and Family Practice Residencies (Table
11). The distribution of overall score by residency specialty is illustrated in Figure 5.
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Table 11: Comparison of Mean Score: Residency Specialty

n

Mean percent
score

Standard
deviation

Pediatrics

51

47.5%*

17.7%

Med/Peds

10

48.0%

13.6%

Pedi Neuro

5

45.3%

28.0%

Family Practice

15

23.1%*

8.0%

Total

81

P value
(ANOVA)

<0.00001

*Significantly lower than overall expected score (56.9%)
Figure 5: Comparison of Mean Score: Residency Specialty

Overall Score by Residency Specialty
Pediatrics

Med/Peds

Pedi Neuro
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Residency Year
Overall percent score was also divided into 5 groups by residency year. Oneway ANOVA showed that percent score overall did not differ significantly by residency
year. However, a trend of increasing percent score with increasing residency year was
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observed. With the exception of the one PGY4 and one PGY5 residents, all scores
were lower than expected and the scores for PGY1 and PGY2 were significantly lower
(Table 12).
Table 12: Comparison of Mean Score: Residency Year
Residency Year

N

Mean score

Std. Dev.

P value
(ANOVA)

PGY1
32
40%*
19%
PGY2
23
42%*
20%
0.417
PGY3
24
47%*
17%
PGY4
1
60%
n/a
PGY5
1
60%
n/a
Total
81
*Significantly lower than overall expected score (56.9%)
Medical School Location – US versus Abroad
Table 13 shows that the majority of residents attended medical school in the
U.S. (82.7%, n=67). Fourteen residents attended medical school abroad. A t-test
comparing the mean overall score between these two groups showed that residents
who attended medical school in the U.S. scored significantly higher overall than those
who attended medical school in another country (Figure 6, p<0.00001). However, a
one-group t test comparing mean overall score for each group to the expected overall
score showed that both groups of residents scored significantly lower than expected
(Table 13). Figure 6 is a graphical representation of the information in Table 13.
Table 13: Comparison of Mean Score: Medical School Location
Location of Medical
School

N

Mean
percent
score
46.7%*
25.0%*

Std. Dev.

P value
(ANOVA)

U.S.
67
18.3%
<0.00001
Abroad
14
9.5%
Total
81
*Significantly lower than expected overall (56.9)
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Figure 6: Comparison of Mean Score Overall: Medical School Location
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Medical School Genetics Rotation
The majority of the respondents (n=53) reported not completing a genetics
rotation during medical school. Eight residents reported that they elected to complete a
genetics rotation while in medical school (n=8) while 20 residents did not provide a
response to this question. ANOVA comparing the three groups resulted in a significant
difference in mean overall percent score (p=0.001) (Table 14). T-tests demonstrated
that the respondents taking an elective genetics rotation scored significantly higher
than both other groups (p= 0.0001, elective compared to no rotation; p=0.0035, elective
compared to no response) and that there was no significant difference in mean score
between the no rotation and no response groups (p=0.830). Not only did the residents
who elected to complete a genetics rotation in medical school score significantly better
than the other two groups, but they also scored significantly higher than expected
overall (65.8% vs. 56.9%, p=0.045). Overall percent scores for the residents who
reported they did not complete an elective rotation and for those residents who did not
provide a response were significantly lower than expected overall. Figure 7 is a
graphical representation of the information in Table 14.
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Table 14: Comparison of Mean Score: Nature of Medical School Genetics
Rotation
Elective Genetics
Mean
P value
Rotation in Medical
N
percent
Std. Dev.
(ANOVA)
School?
score
Yes
8
65.8
10.4%
0.001
No
53
40.7*
16.5%
No response
12
39.7*
21.9%
Total
81
*Significantly lower than overall expected score (56.9%)
Significantly higher than overall expected score
Figure 7: Comparison of Mean Score: Nature of Medical School Genetics
Rotation

Elective Rotation
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Medical School Genetics Curriculum
An examination of overall percent score also revealed that the 39 residents who
received genetics in a dedicated class in medical school scored significantly higher
than the 36 residents who received genetics integrated across their entire curriculum
(p=0.049). As seen in Table 15, the overall mean score for those residents who learned
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about genetics in a dedicated class was 47.6% compared to the overall mean score of
38.8% for those residents who learned genetics in an integrated format.
Table 15: Comparison of Mean Score: Nature of Genetics Class in Medical
School
Nature of Genetics Class

n

Mean
Score
47.6*
38.8*

Std.
Dev.
17.4%
20.8%

P value (ANOVA)

Dedicated Class
39
0.049
Integrated Class
36
Total
75
*Significantly lower than overall expected score (56.9%)
The following variables were also examined but were not found to significantly
affect overall percent score: gender, medical school residency affiliation, whether or not
the residents were post-call, college undergraduate major or minor, whether or not
genetics was taken in college undergraduate, number of children or children under 5,
family history of a genetic condition, length of medical school genetics rotation, and
whether or not residents seek out genetics information via news stories or journal
articles.
Multivariate analysis
The four variables which significantly affected overall score (residency specialty,
medical school location, nature of medical school genetics class, and nature of medical
school genetics rotation) were entered into multivariate analysis. When considered
together, only residency specialty and nature of medical school genetics rotation
significantly affected overall score (adjusted R-squared: 0.331). Family practice
residents scored 19.7% lower on average (p=0.042) than categorical pediatric
residents. The 53 residents who indicated that they did not elect to complete a genetics
rotation scored 20.0% lower on average (p=0.002) than residents who chose to
complete a genetics rotation in medical school.
Redundant and Incorrect Testing Methodologies
There were three scenarios in the survey that gave residents the option to
choose redundant genetic testing – scenario 1 (ambiguous genitalia), scenario 2
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(Fragile X), and scenario 3 (Down syndrome). Since all 81 respondents completed the
three scenarios, there were 243 responses of any type (A, B, C, D, or E). Across all
three scenarios, residents chose redundant genetic testing 30.0% of the time (Table
16).
Table 16: Redundant Genetic Testing Responses
Scenario

Redundant Answer Choices

1: Ambiguous Genitalia

B. CMA + Karyotype
D. CAH biochemical screen + Karyotype
+ CMA

2: Fragile X

C. CMA + Fragile X testing + karyotype
D. CMA + karyotype

15
2

3: Down syndrome

D. CMA + FISH for chromosome 21
E. CMA + Karyotype

22
8

Total Redundant Answers

Answer
Count
6
20

73

Additionally, seven scenarios contained answer choices that would not diagnose
the genetic condition in question. The conditions featured in these scenarios were
Fragile X, SMA, Noonan syndrome, Marfan syndrome, hemoglobinopathy,
achondroplasia and NF1. Eighty-one respondents answered scenario 2 (Fragile X), 72
respondents answered scenario 6 (SMA), and 68 respondents answered each of the
last five scenarios (Noonan, Marfan, hemoglobinopathy, achondroplasia and NF1),
giving a total of 493 possible responses of any type to these questions. When totaled,
residents ordered genetic testing using the wrong methodology 25.6% of the time
(Table 17).
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Table 17: Wrong Methodology Testing Responses
Answer Choices Featuring
Incorrect Methodology
CMA
CMA + Fragile X testing
CMA + Fragile X testing +
karyotype

Answer
Count
5
30

CMA + karyotype

2

CMA

21

CMA only

12

Karyotype for Noonan syndrome

18

12: Marfan syndrome

CMA

3

13: Unspecified
hemoglobinopathy

CMA

2

14: Achondroplasia

CMA

15

Scenario

2: Fragile X

6. SMA
11. Noonan syndrome

15: NF type I
CMA
Total Incorrect Methodology Answer Choices

15

3
126

Cost Analysis
Analysis of health care dollars was performed for select survey questions (Table
18).
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Table 18: Cost Analysis for Select Scenarios
Freq (%)

Total Cost*
($)

34 (42.0)

2,641.75

47 (58.0)

861.75

52 (64.2)

2,411.92

29 (35.8)

390.00

57 (70.4)

2,275.97

24 (29.6)

740.00

Wrong Choices (B,
C, D, & E)

32 (44.4)

2,498.63

Correct Choice (A)

40 (55.6)

Scenario
1. Ambiguous
Genitalia
2. Fragile X
3. Down
syndrome
8. Multiple
Congenital
Anomalies

Wrong Choices (A,
B, C, & E)
Correct Choice (D)
Wrong Choices (A,
B, C, & D)
Correct Choice (E)
Wrong Choices (A,
B, D, & E)
Correct Choice (C)

P value
<0.00001

<0.00001

<0.00001

<0.00001
1,780.00

* Mean total cost except Ambiguous Genitalia, where median was reported

For all four scenarios, the average cost of diagnosis was significantly higher than
necessary when respondents answered incorrectly. For example, in the case of Fragile
X in scenario 2, the price of correct answer choice E, trinucleotide repeat analysis by
DNA Southern Blot for FMR1, is $390 with a >99% detection rate. The other answer
choices for this scenario contain either unnecessary extra testing (choice B, CMA +
Fragile X DNA analysis) or methodologies not able to detect the condition (choice D,
CMA +Karyotype) and all cost significantly more than $390.
Variables Affecting Percent Score
Several variables were tested as possible confounders on correct response rate
and Table 19 lists them along with the scenarios they influenced, as indicated by an
‘X’(p<0.05). Of the 15 scenarios, 9 had at least one variable that significantly influenced
the observed percent correct rate. There were several variables that only affected the
correct response rate for one scenario. Residency specialty was found to be significant
for five of the scenarios, while location of medical school, nature of genetics rotation in
medical school, and number of children affected the correct response rate for three
scenarios.
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X

Sex (Male/Female)
Residency Specialty

X

Residency Year

X

X

X

X

X

X

Undergraduate Major
Med school in the U.S.
or abroad

X

Do you seek out
genetic information
(e.g. news stories,
documentaries)

X

Genetics class in
undergrad

NF1

Achondroplasia

Hemoglobinpathy

Noonan

MCA

New baby
suspected CF

Down syndrome

Fragile X

Ambiguous
Genitalia

Table 19: Variables Affecting Correct Response Rate by Scenario

X

X

Nature of genetics
rotation in medical
school

X

X
X

Number of children

X

Ambiguous Genitalia
Table 20: Correct Responses (%) by Residency Specialty – Ambiguous Genitalia

Wrong
Correct
Total

Pediatrics

Med/Peds

Pedi Neuro

16 (31.4)
35 (68.6)
51

3 (30.0)
7 (70.0)
10

5 (100.0)
0 (0.0)
5

Family
Practice
10 (66.7)
5 (33.3)
15

Total
34 (42.0)
47 (58.0)
81
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For scenario 1 (ambiguous genitalia), residency specialty and residency year
significantly affected the correct answer rate. Med/Peds and categorical pediatric
residents had the highest correct answer rates, (70% and 68.6%, respectively), while
pediatric neurology had the lowest correct answer rate (0%) (Table 20).
Table 21: Correct Responses (%) by Residency Year – Ambiguous Genitalia
PGY1

PGY2

PGY3

PGY4

PGY5

Total

Wrong

13 (40.6)

15 (65.2)

5 (20.8)

0 (0%)

1 (100)

34 (42.0)

Correct

19 (59.4)

8 (34.8)

19 (79.2)

1 (100)

0 (0%)

47 (58.0)

Total

32

23

24

1

1

81

Table 21 demonstrates that the correct response rate dipped initially from year 1
of residency to year 2, but then increased through year 4. However, the correct
response rate was 0% in year 5.
Fragile X
Table 22 Correct Responses (%) by Whether Genetics Was Taken in College –
Fragile X

Wrong
Correct
Total

Yes
43 (70.5)
18 (29.5)
61

No
9 (45)
11 (55.0)
20

Total
52 (64.2)
29 (35.8)
81

Table 23 Correct Responses (%) by Number of College Genetics Classes College
– Fragile X

Wrong
Correct
Total

No genetics
classes
9 (45.0)
11 (55.0)
20

1-2 genetics
classes
41 (70.7)
17 (29.3)
58

3-4 genetics
classes
2 (66.7)
1 (33.3)
3

Total
52 (64.2)
29 (35.8)
81

For scenario 2 (Fragile X), Table 22 shows that residents who took genetics as
an undergraduate student (n=61) were more likely to get the question incorrect than
those who did not take genetics during their undergraduate studies (n=20). However,
even though it was not statistically significant, those residents who took 3-4 genetics
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classes in college were less likely to get the question wrong than those who took 1-2
classes (Table 23).
Down syndrome
Table 24: Correct Responses (%) by Nature of Medical School Genetics Rotation
– Down syndrome

Wrong
Correct
Total

Required
8 (80.0)
2 (20.0)
10 (100.0%)

Elective
2 (25.0)
6 (75.0)
8 (100.0%)

Neither
39 (76.5)
12 (25.5)
51 (100.0%)

Total
49 (71.0%)
20 (29.0%)
69

For scenario three (Down syndrome), residents who elected to complete a
genetics rotation in medical school were more likely to get the question correct than
those who completed one because they were required to and those who did not
complete one at all (Table 24). Residents who did not complete a genetics rotation
were about as likely to get the question correct as those who completed a genetics
rotation because they were required to (25.5% correct vs. 20.0% correct, respectively).
New Baby with Suspected CF
Table 25: Correct Responses (%) by Nature of Medical School Genetics Rotation
– New Baby, Suspected CF
Required

Elective

No rotation

Total

Wrong

6 (60.0)

0 (0.0)

22 (43.1)

28 (40.6)

Correct

4 (40.0)

8 (100.0)

29 (56.9)

41 (59.4)

Total

10

8

51

69

For scenario four (new baby with suspected CF), all residents who completed an
elective genetic rotation in medical school answered the question correctly. Residents
in the other two categories were about as likely to get the question correct as they were
to get it incorrect (Table 25).
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Multiple Congenital Anomalies
Table 26: Correct Responses (%) by Residency Specialty - MCA

Wrong
Correct
Total

Pediatrics
15 (33.3)
30 (66.7)
45

Med/Peds
4 (40.0)
6 (60.0)
10

Pedi Neuro
2 (50.0)
2 (50.0)
4

Family Practice
11 (84.6)
2 (15.4)
13

Total
32 (44.4)
40 (55.6)
72

For scenario 8 (MCA), table 26 shows that the percent correct rate was largely
the same, ranging from 50 to 67% for all specialties except family practice, whose
correct rate was 15.4%.
Noonan syndrome
Table 27: Correct Responses (%) by Residency Specialty - Noonan
Pediatrics

Med/Peds

Pedi Neuro

Family Practice

Total

Wrong

19 (44.2)

8 (80.0)

0 (0.0)

10 (90.9)

37 (54.4)

Correct

24 (55.8)

2 (20.0)

4 (100.0)

1 (9.1)

31 (45.6)

Total

43

10

4

11

68

Table 27 demonstrates that for scenario 11 (Noonan syndrome), 100% of
residents in pediatric neurology got the question correct; while family practice had the
lowest correct rate (9.1%). Pediatrics had the second highest correct rate (55.8%) and
med/peds had the third highest (20%).
Table 28: Correct Responses (%) by Whether Medical School was Attended in the
U.S. - Noonan
Medical School in the U.S.

Medical School Abroad

Total

Wrong

28 (48.3)

9 (90.0)

37 (54.4)

Correct

30 (51.7)

1 (10)

31 (45.6)

Total

58

10

68

40

Table 29: Correct Responses (%) by Whether Residents Seek out Genetics
Information - Noonan
Yes

No

Total

Wrong

7 (35.0)

30 (62.5)

37 (54.4)

Correct

13 (65.0)

18 (37.5)

31 (45.6)

Total

20

48

68

Table 28 shows that the majority of residents who attended medical school
outside of the United States answered the question about Noonan syndrome
incorrectly, while residents who attended medical school in the United States were
about as equally likely to answer the question incorrectly as they were to answer it
correctly. Additionally, residents who reported that they seek out genetics information
were more likely to get the question about Noonan syndrome testing correct than those
who did not report this (Table 29).
Unspecified Hemoglobinopathy
Table 30: Correct Responses (%) by Gender - hemoglobinopathy

Wrong
Correct

Male
6 (31.6)
13 (68.4)

Female
5 (10.4)
43 (89.6)

Total
11 (16.4)
56 (83.6)

Total

19 (28.4)

48 (71.6)

67

For the scenario about an unspecified hemoglobinopathy, female residents were
more likely than males to answer correctly (Table 30).
Table 31: Correct Responses (%) by Residency Specialty - hemoglobinopathy

Wrong
Correct
Total

Pediatrics
3 (7.0)
40 (93.0)
43 (63.2)

Med/Peds
2 (20.0)
8 (80.0)
10 (14.7)

Pedi Neuro
0 (0.0)
4 (100.0)
4 (5.9)

Family Practice
6 (54.6)
5 (45.5)
11 (16.2)

Total
11 (16.2)
57 (83.8)
68

For scenario 13 (hemoglobinopathy), 100% of pediatric neurology residents
answered correctly. Med/Peds and Pediatrics had similar, high correct response rates
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(80% and 93%, respectively). Family practice residents had the lowest correct rate
(45.5%), (Table 31).
Table 32 Correct Responses (%) by Whether Medical School was Attended in the
U.S. - Hemoglobinopathy
Medical School
in the U.S.
6 (10.3)
52 (89.7)
57

Wrong
Correct
Total

Medical School
Abroad
5 (50.0)
6 (50.0)
11

Total
11 (16.2)
57 (83.8)
68

Additionally, for the hemoglobinopathy scenario, residents who went to medical
school in the U.S. had a higher correct response rate (89.7%) than those who went to
medical school outside of the U.S. (54.6%), as seen in Table 32.
Achondroplasia
Table 33: Correct Responses (%) by Residency Specialty - Achondroplasia

Wrong
Correct
Total

Pediatrics

Med/Peds

15 (34.9)
28 (65.1)
43

2 (20.0)
8 (80.0)
10

Pedi
Neuro
0 (0.0)
4 (100.0)
4

Family
Practice
8 (72.7)
3 (27.3)
11

Total
25 (36.8)
43 (63.2)
68

For scenario 14 (achondroplasia), Table 33 shows that residents in pediatric
neurology had a 100% correct response rate, followed by med/peds (80%), then
pediatrics (65%). Family Practice had the lowest correct response rate (27.3%).
Table 34: Number of Correct Responses (%) by Number of Children Achondroplasia

Wrong
Correct
Total

No
children
23 (45.1)
28 (54.9)
51

1 child

2 children

Total

2 (25.0)
6 (75.0)
8

0 (0.0)
9 (100.0)
9

25 (36.8)
43 (63.2)
68

Table 34 shows that percent correct rate increased with increasing number of
children. Respondents with 2 children (n=9) had a 100% correct response rate for the
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scenario involving achondroplasia, while residents with no children were about equally
as likely to answer the question correctly as incorrectly.
Neurofibromatosis Type 1
Table 35: Correct Responses (%) by Undergraduate Major – NF1
Bio/Health

Other Science

Liberal Arts

Total

Wrong

10 (25.6)

9 (66.7)

9 (56.3)

25 (39.1)

Correct

29 (74.4)

3 (33.3)

7 (43.8)

39 (60.9)

Total

39

9

16

64

Table 36: Correct Responses (%) by Number of Children – NF1

Wrong
Correct
Total

No Children
19 (37.3)
32 (62.8)
51

1 Child
7 (87.5)
1 (12.5)
8

2 Children
2 (22.2)
7 (77.8)
9

Total
28 (41.2)
40 (58.8)
68

Table 35 shows that for scenario 15 (NF1), residents with a biology/health
undergraduate major had the highest correct response rate (74.4%). Interestingly,
residents with a liberal arts major had a higher correct response rate than residents
with a major in sciences other than biology (43.8% vs. 33.3%, respectively). Residents
with one child had the lowest correct response rate (12.5%), while residents with two
children had the highest (77.8%) as seen in Table 36.
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Discussion
This study was undertaken to evaluate the baseline genetic testing knowledge
among a selected group of pediatric residents in Houston, Texas. Similar to other
studies of resident knowledge, we found that residents in these pediatric-focused
residency programs had insufficient knowledge of first-tier genetic testing. The mean
overall score was 43.0%, (maximum score of 80% and a minimum score of 0%), which
was significantly lower than the expected mean overall score of 56.9% (p<0.00001).
Additionally, the expected mean overall score was lower than 70%. Since the
importance of genetics in primary care is increasing, it is crucial that physicians are
knowledgeable about genetic testing so that they can better serve their patients.
In the current study, several variables concerning genetics education affected
overall percent score. Perhaps these variables can be explored further to find
innovative ways in which both medical school and residency programs curricula can be
altered to improve baseline genetic testing knowledge.
Variables Affecting Overall Score
Not every resident answered all 15 case-based scenario questions, thus scores
were compared for residents who answered only the first page and residents who
completed the entire survey to determine if genetics knowledge differed for those five
questions. As we did find a significant difference between these two groups of
residents, we feel that the residents who stopped the survey early did so because 1)
they felt the questions were too hard or 2) they had a lack of confidence in their ability
and/or knowledge. Indeed, we found that the mean score on the first five questions for
those residents who stopped after the first page was 24.4%, while the mean score on
those same questions was 46.8% for those residents who finished all three pages
(p=0.024). Furthermore, the overall observed correct score of 43.0% (regardless of
number pages completed) might be an overestimate of this population’s genetics
knowledge if the reason that some residents stopped early was in fact due to lack of
knowledge.
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The mean overall correct score was significantly lower for family practice
residents. We speculate that a lack of genetics training is at least one reason
explaining why these residents scored lower compared to residents from other
programs. Family medicine residency curricula include more varied rotations (e.g.
internal medicine, obstetrician/gynecology, surgery and sports medicine, etc.) and less
time in pediatrics, [41], leaving less time for more specialized rotations such as
genetics. In UT’s family practice residency program, a genetics rotation is not a
requirement. The only genetics experience these residents receive is if they work with a
genetic counselor and/or geneticist during their pediatric/neonatology rotation [55].
Thus, integrating more genetics training into these rotations is probably the best option
for family medicine residency programs, as it is likely that they will encounter a baby
with an underlying genetic condition while in their one short nursery rotation.
The mean overall correct score was significantly lower for residents who
attended medical school abroad compared to those who graduated from medical
schools in the United States. Nearly 86% of our population of foreign medical school
graduates (12 of 15) was comprised of family practice residents. Given that family
practice residents scored lowest overall, we contend that the low scores among foreign
medical school graduates is more reflective of their residency training than of where
they attended medical school. Indeed, once residency specialty was accounted for,
multivariate analysis showed that location of medical school training was no longer a
significant predictor of overall score.
The last variable that affected mean overall correct score was nature of the
genetics rotation in medical school. Residents who elected to complete a genetics
rotation in medical school scored significantly higher than those who did not undertake
a genetics rotation. This is logical considering that residents who elected to complete
such a rotation in their undergraduate medical education were probably interested in
genetics and motivated to retain the information they learned. It should be noted that
the question asking residents if their medical school required a genetics rotation
caused confusion, as no medical schools in the United States are known to require its
students to rotate through genetics. The misunderstanding of this question is further
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evidenced by the fact that 4 residents who reported they attended medical school at UT
indicated they were required to complete a genetics rotation while in medical school,
when it is known that no such requisite exists at UT. Additional limitations of using a
non-validated questionnaire for the study will be addressed later on.
There were several variables that did not affect overall score. Of note, residents
who reported that they seek out genetic information did not score higher than those
who reported that they do not seek out such information. This finding is counterintuitive
one would expect that individuals who seek out genetic information would perform
better than those who do not because they are interested in the subject matter,
motivated to learn, and may retain the information.
Although residency year did not significantly affect the mean overall correct
score, a trend was observed that residents at the end of their training scored higher
than those in the beginning of their training. This pattern is to be expected, as
residents in later years of residency have more overall experience than those in their
earlier years. First-year residents had completed 5 – 8 months of residency by the time
the survey was administered. The majority of their genetics knowledge would have
largely been from their undergraduate medical education. In contrast, physicians in
later years of residency may have had medical school genetics education in addition to
specific genetics training in their residency programs, as well as years of genetics
exposure through experience. At UT, a two-week genetics rotation is now required for
all categorical pediatric residents [56]. Pediatric Neurology residents at UT also
complete this two-week genetics rotation since their residency program consists of the
first two years of categorical pediatrics followed by additional requirements in child
neurology [57]. Internal Medicine/Pediatrics residents at UT must now also complete a
one-month genetics rotation in their fourth year [58], but the family practice residency
program does require any genetics at all [59]. At BCM, genetics is not a required
rotation for any specialty; it is integrated into residents’ curricula through a noon
conference series and direct patient care [60].
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When the individual scenarios were analyzed, we found certain topics that would
benefit from additional instruction in both medical school and residency program
curricula. These topics include: 1. Clarification of the appropriate use of CMA in a
genetics work-up, 2. Clarification of the role of karyotype in genetic diagnosis, and 3.
Clinical actions in the event of a positive newborn screen. Each will be discussed
separately.
Appropriate Use of CMA in a Genetics Work-Up
Since chromosomal microarray analysis (CMA) is a relatively new genetic
testing technology, it was given as an answer choice for 13 of the 15 questions in the
survey but was the correct answer for only one question: scenario 8 (multiple
congenital anomalies). It is encouraging that the majority of responders correctly
answered this question. However, there were several scenarios in which residents
inappropriately selected CMA as the answer choice. For the survey, there were two
ways a CMA could be inappropriate for use in a clinical diagnosis. The first involved the
use of CMA to detect single-gene disorders (e.g. Fragile X, Cystic fibrosis, Noonan,
and achondroplasia). The second involved ordering a CMA in conjunction with another
test when both tests give the same or similar information (i.e. redundant genetic
testing).
It is evident from scenario 2 (Fragile X) that residents do not understand that
there are some genetic conditions CMA cannot detect. Participants were given both the
suspected diagnosis as well as the type of causative mutation (trinucleotide repeat).
However, the majority of respondents (65.2%) chose an answer choice including CMA.
Even if residents did not specifically know the meaning of answer choice E, ‘Order
Fragile X DNA testing,’ four of the five answer choices could have been eliminated as
possibilities had they realized CMA cannot detect trinucleotide repeats. Additionally,
when this question was analyzed using current genetic testing prices, residents spent
an average of $2,000 more than was actually necessary to make the correct diagnosis.
Perhaps genetics education for physicians should make it a priority to focus on the
different types of mutations that cause genetic disease and the testing methodologies
designed to detect them. Grouping genetic conditions by etiology (i.e. conditions
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caused by chromosome aberrations, conditions caused by single genes) would be a
helpful addition to medical school and pediatric-focused residency program curricula. If
no effort is made to correct the deficit of knowledge shown by this survey, health care
dollars will continue to be unnecessarily used.
Similarly, scenario 14 asked residents to order testing helpful in the diagnosis of
achondroplasia. Again, the suspected diagnosis was given for the question although
the type of mutation was not. Nearly one-fourth (22%) of the responders incorrectly
chose CMA, a testing modality that does not detect the two point mutations in FGFR3
responsible for achondroplasia in 99% of affected individuals. More importantly,
achondroplasia remains a clinical diagnosis and molecular testing is not usually
indicated [61]. Molecular testing was not given as an option, and it would have been
interesting to see how often it was chosen if it had been an answer choice.
The Role of Karyotype in Genetic Diagnosis
The clinical scenarios involving Down syndrome and Turner syndrome best
illustrate that residents were not familiar with the correct role of karyotype in genetic
diagnosis. Chromosome analysis via a routine karyotype is the only genetic test
necessary to give a patient a diagnosis of Down syndrome or Turner syndrome. In
addition to a diagnosis, accurate information on both etiology and recurrence risk are
also obtained via karyotype. Almost 10% of residents chose CMA as the correct
answer to scenario 3 (Down syndrome), an observation possibly attributed to the oncecommon practice of ordering the test alongside karyotype when CMA first became
clinically available.
Also in scenario three, roughly half (50.7%) of respondents chose an answer
involving FISH for chromosome 21. It is possible that these were popular answer
choices simply because they were the only ones that made reference to chromosome
21. Moreover, there could also be confusion since aneuploidy FISH is commonly used
to diagnose chromosomal aneuploidies prenatally to facilitate timely decision-making
during pregnancy. Alternatively, residents might be unaware of both the limitations of
FISH for chromosome 21 and the expensive nature of the technology. FISH for
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chromosome 21 can certainly identify three copies of chromosome 21 in the vast
majority of cases, but it cannot differentiate between free trisomy 21 and translocation
21. The difference between free and translocation trisomy 21 is essential in giving
families correct recurrence risk information. Additionally, FISH for chromosome 21
costs several hundred dollars, when the cost of a routine karyotype is all that should be
expended. This extra expense is generally not justified when a non-lethal aneuploidy,
such as Down syndrome, is suspected.
While it is not outside the realm of possibilities that microarray technology, or
something similar, will eventually be able to differentiate between Down syndrome
caused by a translocation and Down syndrome caused by free trisomy 21, currently a
karyotype gives the most complete information needed in a clinical setting. Additionally,
at least one major clinical genetic testing laboratory has explored array technology for
the detection of sex chromosome imbalances like Turner syndrome [62], although there
remain limitations to sensitivity that should be resolved before CMA is ordered in place
of a karyotype.
Clinical Actions in the Event of a Positive Newborn Screen
Residents had the second lowest percent correct rate (6.9%) for the scenario
involving a positive newborn screen for PKU. However, the score on the question is
probably not an accurate assessment of residents’ knowledge for the following
reasons. In the state of Texas, for a positive first newborn screen for PKU, plasma
amino acids should be ordered in conjunction with a consultation and/or referral to a
metabolic specialist [63]. In addition, a second newborn screen should be drawn, if it
has not already been done. The answer choice that the committee deemed correct
was an immediate referral to a metabolic specialist, an answer that does not completely
reflect recommended guidelines. Nearly half of all residents (47%) chose ‘switch the
child to a low phenylalanine diet, order plasma amino acids, and repeat the newborn
screen.’ While we initially chose immediate referral to a metabolic center as the correct
choice, because the overall instructions for the survey state that all answers should be
done in conjunction with a referral to a genetics specialist, this answer choice was
redundant. If used in future surveys, this particular scenario will need to be re-worded.
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It should be noted that the ACT Sheet, provided to physicians by the Texas
Department of State Health Services in the event of a positive newborn screen for
PKU, states that the child’s diet should not be changed until the second screen comes
back positive. Thus, the 68% of residents who selected one of the two answer choices
that included switching their patient’s diet still answered incorrectly. For our survey,
residents were provided space at the end to write comments about the survey and
there were no comments about the question being particularly “tricky.” Respondents’
comments can be found in Appendix E.
Variables Affecting Individual Questions
As stated in the results, there were several variables that significantly affected
the percent correct rate for individual scenario questions. When the observed correct
answer rate for a particular scenario question was affected by one or two variables, it
was likely an artifact of small sample size and not due to a true difference in genetic
testing knowledge. Residency specialty significantly affected observed correct rate for
several questions; however, this could be explained by the fact that family practice
residents performed worse overall than residents from the other three programs.
Possible Ways to Increase Genetic Testing Knowledge Among Primary Care
Providers
Acknowledging that genetics is a rapidly expanding field and that appropriate
testing frequently changes, strategies should be developed to increase genetics
knowledge and keep practicing physicians up-to-date in standard medical practice.
Restructuring undergraduate medical education in genetics like Baylor College of
Medicine (BCM) has done gives students the opportunity to begin learning about
genetics and medicine simultaneously as early as possible. It would be illuminating to
perform a study similar to this one comparing medical residents who completed a
genetics track while in medical school to those that did not. In fact, BCM has such
longitudinal studies planned for the future [45]. However, it is expected that only those
medical students who choose to focus on genetics during medical school will have
increased knowledge.
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For students who do not choose a genetics track, supplemental education is
needed from another source. Several studies of physicians have suggested that current
genetics instruction is too focused on rare disorders and not focused enough on
common conditions like high cholesterol [48]. To increase clinical relevance of genetics,
it has been advocated that medical schools teach genetics in an integrated manner
and/or teach genetics in a way that is clearly applicable to a particular clinical specialty
[64,65]. Our data did not support the fact that integrated teaching was better for
medical school genetics instruction, as residents who had a dedicated genetics class
scored higher overall than those who had genetics integrated into their curricula. It
should be noted however, that our data was only on the cusp of statistical significance
and perhaps with a bigger study population, there might have been a different result
Another way to increase knowledge regarding genetic testing could be to tailor
clinical scenarios to particular trainees depending on their chosen specialty. For
example, autosomal dominant inheritance might be best taught to a cardiologist using
Marfan syndrome as an example, while achondroplasia might be most useful for
orthopedic trainees. But regardless of the chosen method and examples used, genetics
education must extend from instruction about natural history and inheritance patterns to
appropriate baseline clinical testing for these conditions (e.g. echocardiograms for
suspected Marfan syndrome and skeletal surveys for suspected achondroplasia).
Reigert-Johnson, et al. (2004) highlighted several potential areas of
improvement for genetics education. A notable proposal was that residents be formally
supervised by a member of a genetics department [66]. However, due to the paucity of
genetics professionals in healthcare practice, it would be difficult to execute this idea
[67]. Although it could be ideal, long new patient wait lists would prevent most clinical
geneticists from entering into such agreements with primary care practices. An
academic medical center would be better able to implement the suggestion, but even
our clinical pediatric service at UT in the Texas Medical Center has found that such an
agreement would be impossible given our high patient volume. Another potential
solution provided by Reigert-Johnson, et al. is participation of medical geneticists in
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Morbidity and Mortality (M&M) conferences, thus encouraging physicians to consider
and appreciate the contribution of genetics to illness.
Addressing deficits of genetics education in medical school and residency
programs still leaves the very large population of practicing physicians who are no
longer in residency but need to be kept current on rapidly changing genetic testing
technology. To remedy the problem, credentialing should consider endorsing geneticsfocused CME opportunities.
Other potential solutions exist to encourage PCPs to work collaboratively with
medical geneticists and genetic counselors. Since we have established that medical
geneticists likely do not have the time required to supervise residents in practice, these
healthcare professionals could choose to mentor in other ways. At UT, medical
geneticists and genetic counselors regularly give grand rounds presentations about
genetics and genetic testing to attending and resident physicians on a variety of topics
including genetic testing and newer technology such as Non-invasive Prenatal
Diagnosis (NIPD). Given that genetic counselors are specifically trained to explain
complex genetic concepts to individuals with varying knowledge bases, perhaps
genetic counselors can invite their pediatrician colleagues to such presentations. Such
multi-disciplinary collaboration would likely increase PCP knowledge and their
understanding of the role genetics plays in disease.
Building on the idea of multi-disciplinary collaboration, we propose that pediatricfocused PCPs should consult their genetic-focused colleagues more when
encountering a patient who could have an underlying genetic condition. Examples
might include consulting with a geneticist or genetic counselor about appropriate firsttier genetic testing to order or asking whether a child would benefit from a referral to a
genetics specialist. Collaboration in hospitals or doctors’ offices when genetic testing is
being ordered could potentially decrease the monetary burden of genetic services on
the health care system. In addition, similar to ARUP, more laboratories could use
genetic counselors to assess their testing requests to decrease duplicate or redundant
genetic testing. Furthermore, LBJ General Hospital in Houston, TX is piloting a genetic
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screening clinic program with certified genetic counselors evaluating children and their
family histories to recommend appropriate genetic testing before the child has an
appointment with the medical geneticist. The idea of a pediatric genetics screening
clinic has the potential to help with both over-crowded genetics clinics and with
reducing unnecessary genetic testing.
Strengths and Limitations
Our study is the first to focus on the current use of Chromosomal Microarray
Analysis in primary care and has provided preliminary evidence that pediatrics-focused
residents are aware of the test but do not understand its appropriate use. In addition,
cost analysis was incorporated into our study. This was found to be a limitation to
previous studies of physician knowledge of genetics [31].
We have examined the lack of genetics knowledge among health care providers
in a novel way; however we acknowledge some limitations to our study. The limitations
include self-reported data, small sample size (n=81) and use of a non-validated
questionnaire. As mentioned previously, it appears that the demographic question
regarding a required genetics rotation in medical school caused confusion, since 10
residents indicated their medical schools required a genetics rotation. If this survey is
used again in the future, this question will need to be reworded since there are no
medical schools in the United States known to require such a rotation of its students.
Repeating this study with greater number of residents and a validated survey tool
would make the results more generalizable. Furthermore, we were not able to recruit
family practice residents from BCM. If the BCM family practice residents had
participated, the overall score of family practice residents may have been higher.
However, it should be noted that medical school affiliation for residency programs did
not significantly affect overall score for the other three specialties, so family practice
residents from BCM may have performed poorly as well.
We also acknowledge that the correct answer for each case-based scenario
question was determined by a small number of practicing genetics professionals. While
every effort was made to ensure that our determination of the correct answer was in
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line with current guidelines and recommendations, we concede that standard of care is
different among institutions.
We anticipated that residents might use down time to answer the survey (i.e.
answering the questions in an on-call room), so we had to enable multiple answers per
computer to get the highest response rate. Additionally, although we asked residents to
answer the questions from their own knowledge and not to consult any references, we
cannot guarantee that they did not do so. Since residents had low genetic testing
knowledge overall, we do not expect that any such collaboration would have
significantly increased percent score overall.
Future Directions
A study of a larger group of residents who elected to take genetics in medical
school to assess how they initially became interested in genetics could be enlightening.
Such an analysis might highlight ways to increase the population of medical students
who have an interest in genetics. Also, just as we have suggested that primary care
physicians should collaborate more with genetics professionals, the genetics work force
should make every effort to ensure that genetics resources are up-to-date. For
example, ‘Genetic Testing 101’, an educational resource published by the National
Coalition for Health Professional Education in Genetics, does not contain any
information about array-CGH technology [68].
Conclusions
In conclusion, the results of the current study supported our contention that
pediatrics-focused are deficient in their knowledge about first-tier genetic testing as it
pertains to clinical practice. While previous studies have focused on physician recall of
genetic information, this study asked residents to apply what they knew about genetics
to a clinically based scenario that they might encounter in practice and determine the
most appropriate first-tier genetic testing needed.
Additionally, we have provided preliminary evidence of possible excess health
care spending in the course of diagnosing certain genetic conditions. This concept
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should be explored further with future studies since health care costs in the United
States continue to rise.
Through this study, we identified several topics for clarification with regard to
genetic testing that can be used in medical education: appropriate use of CMA in the
genetics work-up, the role of karyotype in genetic diagnosis, and clinical actions to be
taken in the event of an abnormal newborn screen.
Several previously proposed remedies for addressing deficient health care
provider genetics knowledge were also explored in the context of the results of this
study. It is our hope that medical schools and residency programs continue to alter their
curricula to make genetics education the most relevant it can be to clinical practice.
Ultimately, strides must be taken to overcome this deficient in knowledge in first-tier
genetic testing among pediatric-focused health care providers to ensure that families
receive the best care possible in both a timely fashion and at a reasonable expense.
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Appendix A – Demographic Questions and Survey
Study Questionnaire – Demographic Information
Demographics
Please complete all of the following questions:
Age: ______________
Sex:
Male
Female
Which residency specialty training program are you in currently?
Pediatrics
Combined Internal Medicine/Pediatrics
Pediatric Neurology
Family Practice
Other - please specify ___________________
In what year of residency are you currently?
1st
2nd
3rd
4th
Are you post-call today? Yes
No
Undergraduate demographic questions
Did you obtain an undergraduate degree before attending medical school?
Yes
No
If yes:
What was your undergraduate major? ________________________
What was your undergraduate minor? ________________________
If no, please describe your education prior to entering medical school:
_________________________________________________________
Do you have any post-undergraduate degrees?
Yes
No
If yes, which other degrees do you have? ___________________
How many genetic courses did you take in your undergraduate training?
0
1-2
3-4
5+
Medical school demographics questions
Did you attend medical school in the United States?
Yes
No
If Yes:
From which medical school did you graduate? ________________
In which state is this medical school located? ________________
If No:
From which medical school did you graduate? _________________
In which country is this medical school located? _______________
How many genetic courses did you take in medical school?
0
1-2
3-4
5+
Did your medical school require a Genetics rotation?
Yes
No
If yes, how many weeks was your genetics rotation? ____________________
If no, did you elect to complete a genetics rotation?
Yes
No
How many weeks was this elective genetics rotation? _______________
Do you have children?
Yes
No
If yes, how many? _________
How many of your children are under the age of 5? ________
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Have any of your children or family members been diagnosed with a genetic condition?
Yes
No
If yes, what is the genetic condition? __________________________________
Other
Have you ever taken a genetics class as an elective (i.e. not required by your degree
program)? Yes
No
If yes, how many?
1
2
3
4+
Do you subscribe to any scientific journals that are genetics-focused?
Yes
No
If yes: to which genetics-focused journals do you subscribe? _______________
Do you seek out genetics information (i.e. news stories, T.V./movie documentaries,
etc.)
Yes No
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Genetic Testing Knowledge Survey
Directions: Please read each scenario and choose the single, best answer, looking
for the most appropriate first tier genetic test/clinical action to consider when
evaluating a patient with a potential underlying genetic condition. This genetic
test/clinical action should be in conjunction with a referral to a genetics
specialist.
1. A 39-week G2P1 female delivers a baby weighing 3,200 g and measuring 50 cm
long. This baby appears male but is determined to have ambiguous genitalia with
stretched penile length of about 2 cm. The gonads are not palpable. How would you
proceed?
A.
Order Chromosomal Microarray Analysis (CMA)
B.
Order Chromosomal Microarray Analysis (CMA) + Karyotype
C.
Order Congenital Adrenal Hyperplasia (CAH) biochemical screen
D.
Order Congenital Adrenal Hyperplasia (CAH) biochemical
screen + Karyotype
E.
Order Congenital Adrenal Hyperplasia (CAH) biochemical screen
+ Karyotype + Chromosomal Microarray Analysis (CMA)
2. You have been following a 6-year-old male in your clinic with a history of significant
intellectual disability, autistic features, and dysmorphic features consistent with
Fragile X syndrome. Fragile X syndrome, a common genetic cause of intellectual
disability, is due to a trinucleotide (CGG) repeat in the FMR1 gene on the X
chromosome. How would you proceed?
A.
B.
C.
D.
E.

Order Chromosomal Microarray Analysis (CMA)
Order Chromosomal Microarray Analysis (CMA) + Fragile X testing
Order Chromosomal Microarray Analysis (CMA) + Fragile X testing + karyotype
Order Chromosomal Microarray Analysis (CMA) + karyotype
Order Fragile X testing

3. A full-term female baby is born to a G1P0 mother with Apgar scores of 9 and 10 at 1
and 5 minutes respectively. Upon examination, you note the baby has almondshaped eyes, epicanthal folds, a flattened face, and protruding tongue. You suspect
this baby girl has Down syndrome. After talking to the mother, you learn that her
sister also had a child with Down syndrome. How would you proceed?
A.
B.
C.
D.

Order Chromosomal Microarray Analysis (CMA)
Order Fluorescence In-situ Hybridization (FISH) for chromosome 21
Order a karyotype
Order Chromosomal Microarray Analysis (CMA) + Fluorescence In-situ
Hybridization (FISH) for chromosome 21
E. Order Chromosomal Microarray Analysis (CMA) + Karyotype
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4. You follow a 3-month-old Caucasian baby with a history of failure to thrive. At birth,
the baby had meconium ileus, and has since had a history of failure to thrive.
Newborn screening for immunoreactive trypsinogen (IRT) was high and a sweat test
was inconclusive. You suspect Cystic Fibrosis, which is caused by mutations in
CFTR. How would you proceed?
A.
B.
C.
D.

Order CFTR deletion testing
Order CFTR full sequencing to look for mutations in the gene
Order CFTR common mutation panel to look for mutations in the gene
Order Chromosomal Microarray Analysis (CMA) to look for absence or
duplication of CFTR gene
E. Order Chromosomal Microarray Analysis (CMA) + CFTR common mutation
panel

5. The maternal aunt of the baby in the previous question is starting to plan her family.
Due to her nephew’s genetic testing and subsequent parental testing, she knows
that her sister carries a deltaF508 mutation in one of her copies of the CFTR gene.
She decides to pursue testing and discovers that she carries this mutation as well.
Her husband is of Latino ancestry. What is the most appropriate testing for him as
he pursues carrier screening?
A.
B.
C.
D.
E.

CFTR deletion testing
CFTR full sequencing to look for mutations in the gene
Targeted CFTR mutation testing to see if he also carries the deltaF508 mutation
CFTR common mutation panel to look for mutations in the gene
Chromosomal Microarray Analysis (CMA) to look for absence or duplication of
the CFTR gene

6. The parents of one of your patients tell you they are concerned because their 10month-old daughter’s fingers have started trembling. You note that the baby can sit
on her own but has generalized muscle weakness and absent tendon reflexes. You
suspect the baby might have Spinal Muscular Atrophy (SMA), which is caused by
mutations in SMN1. How would you proceed?
A. Order deletion/duplication testing of SMN1 to look for deletions & duplications
B. Order Chromosomal microarray (CMA) to look for deletion or duplication of
SMN1
C. Order sequencing of all exons of SMN1
D. Order sequencing of only exons 7 and 8 of SMN1
E. Order targeted deletion analysis of exons 7 and 8 of SMN1
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7. You see a 28-month-old boy as a new patient in your clinic that has developed
severe hyperphagia. His mother tells you she has put locks on all cabinets
containing food. His mother is very confused because when her son was a baby, he
never liked to eat and even had a history of failure to thrive. His mother tells you that
her son never does what she asks him to do and throws frequent temper tantrums.
Upon examination, you note the child has a hypoplastic scrotum and cryptorchidism.
You suspect this child might have Prader Willi syndrome, which is caused by
mutations in SNRPN. How would you proceed?
A.
B.
C.
D.
E.

Order Chromosomal Microarray Analysis (CMA)
Order FISH for the Prader Willi critical region
Order methylation studies of the Prader Willi critical region
Order sequencing of SNRPN
Order testing for uniparental disomy (UPD) of Prader Willi critical region

8. You see a 3-year-old boy in your clinic as a new patient. This child has general
dysmorphic features and multiple congenital anomalies that do not particularly match
any one syndrome. He also has severe motor and developmental delay. How would
you proceed?
A.
B.
C.
D.
E.

Order Chromosomal Microarray Analysis (CMA)
Order a karyotype
Order fragile X testing
Order a telomere FISH panel
Order a metabolic work-up (plasma amino acids, urine organic acids,
acylcarnitine profile)

9. One of your adolescent patients, a 16-year-old girl, comes in with her mother for
primary amennorhea. Physical exam reveals that this patient is below the 3rd
percentile for height, has some hearing loss and preliminary labs reveal
hypothyroidism. How would you proceed?
A.
B.
C.
D.

Order Chromosomal Microarray Analysis (CMA)
Order a karyotype
Order a skeletal survey
Order a metabolic work-up (plasma amino acids, urine organic acids,
acylcarnitine profile)
E. Order a telomere FISH panel
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10. A 2-week-old baby girl comes to your clinic with one positive newborn screen for
hyperphenylalaninemia suggestive of Phenylketouria (PKU). PKU is caused by
mutations in the gene for phenylalanine hydroxylase (PAH). How would you
proceed?
A.
Order plasma amino acids and serum phenylalanine hydroxylase levels
B.
Immediately refer the child to a metabolic center
C.
Order sequencing of the phenylalanine hydroxylase (PAH) gene and
switch the child to a low phenylalanine diet.
D.
Repeat the newborn screen and switch the child to a low phenylalanine
diet
E.
Switch the child to a low phenylalanine diet, order plasma amino acids,
and repeat the newborn screen
11. You are referred a new male patient whose family has just moved to Houston from
out-of-town. This patient is below the 3rd percentile in height, has a VSD, and
developmental delay. He also has a broad, webbed neck, apparently low-set
nipples, an unusually shaped chest, and characteristic facies (low-set, posteriorly
rotated ears with fleshy helicies, epicanthal folds, and ptosis). How would you
proceed?
A.
B.
C.
D.
E.

Order Chromosomal Microarray Analysis (CMA)
Order a karyotype for Noonan syndrome
Order a karyotype for Turner syndrome
Order molecular testing for Noonan syndrome
Order molecular testing for Turner syndrome

12. You see a 15-year-old male patient who has just moved here from Argentina. He is
>97th percentile for height, has a high arched palate, long limbs, pectus excavatum.
It is unknown whether he is shares some of these characteristics with other family
members. How would you proceed?
A. Order Chromosomal Microarray Analysis (CMA)
B. Order an echocardiogram, ophthalmologic exam, homocysteine and
methionine panel
C. Order a metabolic workup (plasma amino acids, urine organic acids,
acylcarnitine profile)
D. Order an echocardiogram and ophthalmologic exam
E. Order sequencing of the RET gene responsible for Multiple Endocrine Neoplasia
type 2
13. You see a 2-week-old baby in clinic whose newborn screen results and CBC are
suggestive of a hemoglobinopathy. How would you proceed?
A. Order Chromosomal Microarray Analysis (CMA)
B. Order full sequencing of the FVIII and FIX genes responsible for Hemophilia
types A and B
C. Order full sequencing of the HBB gene responsible for sickle cell disease
D. Order a hemoglobin electrophoresis if not already done
E. Order sickledex analysis if not already done
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14. You see a 10-month-old child for his well-child exam and you notice that he has
fallen off the growth curve. On physical exam, he has rhizomelic (proximal)
shortening of the limbs, frontal bossing and midface hypoplasia. You believe this
child most likely has achondroplasia. How would you proceed?
A.
B.
C.
D.
E.

Order Chromosomal Microarray Analysis (CMA)
Order a metabolic workup (plasma amino acids, urine organic acids,
acylcarnitine profile)
Order serum calcium levels
Order a skeletal survey
Order vitamin D studies

15. A 4-year-old female new to your clinic presents with 20 café au lait (coffee colored)
macules greater than or equal to 5 mm in diameter, most commonly on the trunk
and least commonly on the head and neck. You notice she also has freckling under
her arms, a speech impediment, is <5th percentile for height and >95th percentile for
FOC. You suspect this child has neurofibromatosis. How would you proceed?
A.
B.
C.
D.
E.

Diagnose neurofibromatosis based on clinical criteria
Diagnose neurofibromatosis after molecular testing comes back positive
Diagnose neurofibromatosis after skin biopsy studies come back positive
Order a Chromosomal Microarray Analysis (CMA)
Order an echocardiogram
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Appendix B – Cover Letter/Consent Form

Dear participants,
The purpose of this survey is to assess residents' baseline knowledge regarding
diagnostic strategies for genetic diseases. This study is composed of 15 multiple
choice, scenario-based questions which we hope will allow greater understanding of
current knowledge regarding this topic. Space is available for additional comments
should you find this necessary.
Please complete the demographic data and then answer the short survey. Do not write
any information on the survey which would identify you personally. Please complete the
survey from your own knowledge offhand and please do not use any outside resources,
including other healthcare professionals.
Completion of this anonymous survey is voluntary and for research purposes only. No
information will be associated with any individual participant. Your answers will not be
available to any of your instructors or to your program director and will in no way be
used to evaluate you in your program. Data will be analyzed in aggregate and
presented as part of a thesis project at the University of Texas Graduate School of
Biomedical Sciences at Houston. By completing and submitting this survey, you are
implying consent to have your answers used and shared among collaborators for this
study. There is no financial compensation for taking this survey.
After the completion of my project, the answers to my questions will be made available
to you, should you be interested. If you have questions or concerns, please contact
Samantha Penney or Sarah Noblin, MS, CGC at 713-566-5938.
Thank you again for your participation.
Samantha Penney
UT Genetic Counseling Student
The University of Texas Graduate School of Biomedical Sciences at Houston
Principle Investigator
Sarah J. Noblin, MS, CGC
Assistant Director, UT Genetic Counseling Program
The University of Texas Health Science Center at Houston
Department of Pediatrics
Committee Chair
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Appendix C – Test Pricing
Test
CMA
Karyotype
FISH for Chromosome 21
Fragile X trinucleotide repeat analysis
CAH screen
Telomere FISH
Plasma Amino Acids
Urine Organic Acids
Acylcarnitine Profile
Molecular testing for Noonan (PTPN11 sequencing)
Echocardiogram (does not include technical fees or
interpretation)
Ophthalmologic Exam
RET sequencing

Price ($)
1780
740
630
390
121.75
1030
235
253
311
1750
1700
205
1380
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Appendix D – Variables Tested for Significance

Gender
Residency specialty
Residency year
Med school affiliation
Post-call
Undergrad major
Undergrad minor
Any genetics in undergrad (Y/N)
Med school in U.S. (Y/N)
Number of children
Children under 5 years
Family history of genetic condition (Y/N)
Set-up of genetics classes in medical school (dedicated/integrated/not addressed)
Required genetics rotation med school (Y/N)
Year genetics was taken in med school
Nature of genetics rotation (none/required/elective)
Length of elective genetics rotation
Number of genetics classes in college undergraduate
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Appendix E – Free Response Comments About the Survey
“too long”
“I’d be fascinated to get feedback on how I did.”
“I would like to know the answers when the study is done. That would be helpful and
informative for my practice. Thanks! Great survey!”
I would love to be able to get feedback on my responses.”
“Too long”
“It would be nice to have the answers to these questions!”
“I probably got most of these wrong but I don’t believe in pan-CMAing people”
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